Apyx Medical (APYX) Return on Capital Employed (2011 - 2026)

Apyx Medical has reported Return on Capital Employed for 16 years, with the latest figure at 0.24% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 2859.0% year-over-year to 0.24%; the trailing twelve-month figure through Mar 2026 stood at 0.24% (up 2859.0% YoY), and the FY2025 full-year result was 4.2%, up 2653.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 0.24%, up from 4.51% in the prior quarter.
• The five-year high for Return on Capital Employed was 0.24% in Q1 2026, with the low at 65.17% in Q1 2023.
• Historically, Return on Capital Employed has averaged 33.02% across 5 years, with a median of 34.39% in 2023.
• Annual changes were most pronounced in 2023 — Return on Capital Employed plunged 3647 bps — and 2024, when it jumped 3682 bps.
• Apyx Medical's Return on Capital Employed stood at 56.54% in 2022, then soared by 46 bps to 30.49% in 2023, then dropped by 19 bps to 36.2% in 2024, then soared by 88 bps to 4.51% in 2025, then soared by 95 bps to 0.24% in 2026.
• The last three Return on Capital Employed figures came in at 0.24% (Q1 2026), 4.51% (Q4 2025), and 20.31% (Q3 2025), per Business Quant data.